SNES - SenesTech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.3500
+0.0200 (+1.50%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.3300
Open1.3800
Bid1.3500 x 1200
Ask1.3700 x 1000
Day's Range1.3300 - 1.4000
52 Week Range0.5500 - 1.9500
Volume231,966
Avg. Volume256,392
Market Cap34.057M
Beta (3Y Monthly)1.76
PE Ratio (TTM)N/A
EPS (TTM)-0.5640
Earnings DateMar 27, 2019 - Apr 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.75
Trade prices are not sourced from all markets
  • GuruFocus.com18 hours ago

    Insiders Roundup: Garmin, Dolby

    Largest insider trades of the week Continue reading...

  • GuruFocus.com2 days ago

    Senestech Inc (SNES) CEO Kenneth S Siegel Bought $940,000 of Shares

    CEO of Senestech Inc (30-Year Financial, Insider Trades) Kenneth S Siegel (insider trades) bought 696,296 shares of SNES on 07/16/2019 at an average price of $1.35 a share. Continue reading...

  • PR Newswire3 days ago

    SenesTech Announces Closing of Public Offering of Common Stock

    FLAGSTAFF, Ariz., July 17, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced that it has closed the public offering of common stock, as was announced on Thursday, July 11, 2019, with gross proceeds of $4.1 million. The offering was common stock only and did not include dilutive warrants. The proceeds allow the Company to fully engage in sales and marketing efforts in California and other target markets.

  • Does Market Volatility Impact SenesTech, Inc.'s (NASDAQ:SNES) Share Price?
    Simply Wall St.5 days ago

    Does Market Volatility Impact SenesTech, Inc.'s (NASDAQ:SNES) Share Price?

    Anyone researching SenesTech, Inc. (NASDAQ:SNES) might want to consider the historical volatility of the share price...

  • PR Newswire8 days ago

    SenesTech Announces Pricing of $4.1 Million Public Offering of Common Stock

    FLAGSTAFF, Ariz., July 11, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced  the pricing of its previously announced public offering of 3,037,038 shares of its common stock at a price to the public of $1.35 per share. SenesTech expects to receive aggregate gross proceeds of approximately $4.1 million from the offering. The shares of common stock are being offered by SenesTech pursuant to a "shelf" registration statement on Form S-3 (Registration No. 333-225712) previously filed with and declared effective by the Securities and Exchange Commission (the "SEC") on August 24, 2018.

  • PR Newswire9 days ago

    SenesTech Announces Proposed Public Offering of Common Stock

    FLAGSTAFF, Ariz., July 11, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced that it intends to offer and sell shares of its common stock in a public offering.  The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The shares of common stock are being offered by SenesTech pursuant to a "shelf" registration statement on Form S-3 (Registration No. 333-225712) previously filed with and declared effective by the Securities and Exchange Commission (the "SEC") on August 24, 2018. A preliminary prospectus supplement describing the terms of the offering will be filed with the SEC and will form a part of the effective registration statement.

  • PR Newswire10 days ago

    California Bill to Ban SGAR Rodenticides Clears Senate Natural Resources & Water Committee

    FLAGSTAFF, Ariz., July 10, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announces that AB 1788, the California Ecosystems Protection Act, has moved into the final stretch for approval with the "do pass" action at the Senate Natural Resources and Water Committee today.  AB 1788, would ban the use of Second Generation Anticoagulant Rodenticides (SGARs) throughout the state of California, with certain exceptions, and would also ban the use of First Generation Anticoagulant Rodenticides (FGARs) on state-owned lands. The high toxicity and persistence of these rat poisons is responsible for the poisoning and contamination of mountain lions, bobcats and hawks and other wildlife that prey on poisoned rats and animals that have consumed the rats.

  • PR Newswire19 days ago

    SenesTech Joins the Russell Microcap Index

    FLAGSTAFF, Ariz., July 1, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it has been added to the Russell Microcap® Index effective after the market close on Friday, June 28, 2019, as part of the Russell Indexes annual reconstitution. Ken Siegel, Chief Executive Officer of SenesTech, said, "We are extremely pleased to have been selected to join the Russell Microcap Index. FTSE Russell is a leading global index provider creating and managing a wide range of indexes, data and analytic solutions to meet client needs across asset classes, style and strategies.

  • PR Newswirelast month

    California Bill to Ban SGAR Rodenticides Clears Senate Environmental Quality Committee

    FLAGSTAFF, Ariz., June 20, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announces that AB1788, which will ban the use of Second Generation Anticoagulant Rodenticides (SGARs), has moved another step closer to becoming law. "It was a privilege to be invited to testify before the Senate committee meeting today to support California's consideration of a bill that will propel the state forward in its environmental stewardship.  I was joined by our Vice President of Scientific Operations, Brandy Pyzyna and Dr. Stephen Shuster of Northern Arizona University," said Dr. Loretta Mayer, Chief Scientific Officer and co-Founder of SenesTech.

  • PR Newswire2 months ago

    SenesTech to Present at the LD Micro Invitational on June 5, 2019

    FLAGSTAFF, Ariz., May 21, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be presenting at the LD Micro Invitational at Luxe Hotel in Bel Air, California. The Senes Tech presentation will be made by Tom Chesterman, the Company's CFO, on Wednesday, June 5th at 11:20 am Pacific Time. SenesTech has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control.

  • PR Newswire2 months ago

    SenesTech Announces Financial Results and Appointment of Ken Siegel as Chief Executive Officer

    Hospitality-veteran and former Executive Officer of Starwood Hotels & Resorts Ken Siegel Named Chief Executive Officer Dr. Loretta Mayer to Remain Chair and Chief Scientific Officer FLAGSTAFF, Ariz. , ...

  • PR Newswire2 months ago

    SenesTech, Inc. to Report First Quarter 2019 Financial Results on Wednesday, May 15, 2019

    FLAGSTAFF, Ariz., May 9, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its first quarter of 2019, ended March 31, 2019, after the market close on Wednesday, May 15, 2019. The Company has scheduled a conference call that same day, Wednesday, May 15, 2019, at 5:00 pm ET, to review the results. Call-in Information: Interested parties can access the conference call by dialing (844) 308-3351 or (412) 317-5407.

  • PR Newswire2 months ago

    California Bill AB1788 to Ban SGAR Rodenticides Clears Assembly

    FLAGSTAFF, Ariz., May 6, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announces that California's AB1788, which will ban the use of Second Generation Anticoagulant Rodenticides (SGARs), has been passed by the State Assembly. "With this, California has moved a step closer to the creation of  the California Ecosystems Protection Act of 2019 which will prohibit the use of the four major Second Generation Anticoagulant Rodenticides (SGARs) commonly used in rodent pest control.  As the State of California moves toward a new paradigm in pest management it is becoming clear that the concept of balance between humans and animals is being demanded with a loud voice.  We applaud the bold step in asking industry to come forward with a solution.  We are working with industry professionals and end-users to add ContraPest, our fertility control flagship product, to their rodent management solution strategies," said Dr. Loretta Mayer, CEO of SenesTech.

  • PR Newswire3 months ago

    Pestec Expands ContraPest® in California to Serve the Bay Area

    "San Francisco is a hub of culture, commerce and biodiversity," said Luis Agurto, President and CEO of Pestec.  "The conditions that drive this vibrancy are the same conditons that drive all life, including rats.

  • Is SenesTech's (NASDAQ:SNES) 236% Share Price Increase Well Justified?
    Simply Wall St.3 months ago

    Is SenesTech's (NASDAQ:SNES) 236% Share Price Increase Well Justified?

    The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you pick the right stock, you can make a lot more than 100%. For example, the SenesTech, Inc. (NASDAQ:SNES) share price had mo...

  • PR Newswire3 months ago

    California Bill to Ban SGAR Rodenticides Clears Appropriation Committee

    FLAGSTAFF, Ariz., April 24, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announces that AB1788, which would ban the use of Second Generation Anticoagulant Rodenticides (SGARs) has moved another step closer to becoming law. "It is becoming clear to us that within the State of California, the demand for more ecologically sensitive products continues to grow and it is not a question of 'if,' it is a question of 'when' this legislation becomes law.

  • PR Newswire3 months ago

    SenesTech Expands Digital Reach with Addition of "Newsroom" to its Website

    "Keeping up with the escalating growth of interest in our innovation places a big 'ask' on our Marketing Department. "When it comes to our commitment to innovating pest management products and processes, communication with our customers is key.

  • PR Newswire3 months ago

    ContraPest® is THE Answer to the Recommendation by the California Department of Fish and Wildlife Alert as AB 1788 Clears Critical Hurdle

    FLAGSTAFF, Ariz., April 15, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, provides a long term solution within the state of California specifically in response to the recommendation by California Department of Fish and Wildlife: i.e. On April 11, 2019, the CDFW published in the California Fish and Wildlife News (https://cdfgnews.wordpress.com/2019/04/11/plentiful-precipitation-pumps-up-rodent-populations/) that with the increased precipitation experienced in California rodent populations are increasing, and in addition to the increased rodent population growth, "…CDFW reminds people that rodenticides can also kill non-target wildlife, and even pets and children." This alert comes only days after AB1788 (the Bill that would create the California Ecosystems Protection Act of 2019 and, in short, prohibit the use of the four major Second Generation Anticoagulant Rodenticides (SGARs) commonly used in rodent pest control) passed the Assembly Water, Parks and Wildlife committee with a vote of 8 Ayes, 5 Noes.

  • PR Newswire4 months ago

    SenesTech's ContraPest® Offers a Non-SGAR Rodent Control Solution to California Pest Management Professionals

    FLAGSTAFF, Ariz., April 4, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, fully supports and underscores their alignment with their California pest management professionals who are concerned with balancing rodent control with the protection of non-target wildlife species, by providing an effective non-lethal tool for rodent management, ContraPest®. The Assembly of the State of California is once again considering a bill to amend the Food and Agricultural Code relating to pesticides (AB1788).

  • PR Newswire4 months ago

    SenesTech Announces Commercial Acceleration With New Senior Vice President, Edward Albe

    FLAGSTAFF, Ariz., April 3, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, is excited to announce that Ed Albe has joined SenesTech as Senior Vice President of Commercialization. "In our earnings call last Thursday, we discussed our commercial accomplishments cast in the structure of our new commercial verticals of Structural/Cities, Food Production, Storage, and Animal Facilities. We introduced this strategy as a prelude to our addition of Ed Albe to our team," commented Dr. Loretta Mayer, CEO and co-founder of SenesTech.

  • GuruFocus.com4 months ago

    SenesTech Inc (SNES) Files 10-K for the Fiscal Year Ended on December 31, 2018

    SenesTech Inc is a biotech platform and research company. The Company is engaged in developing technology for managing animal pest populations through fertility control. Warning! GuruFocus has detected 3 Warning Signs with SNES.

  • PR Newswire4 months ago

    SenesTech Announces Fiscal 2018 Financial and Operational Results

    FLAGSTAFF, Ariz. , March 28, 2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced ...

  • PR Newswire4 months ago

    SenesTech to Present at the Spring Investor Summit in New York on April 2, 2019

    FLAGSTAFF, Ariz., March 27, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be presenting at the Spring Investor Summit at The Essex House in New York City. The SenesTech presentation will be made by Tom Chesterman, the Company's CFO, on Tuesday, April 2nd at 11:00 am Eastern Time. SenesTech has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control.

  • PR Newswire4 months ago

    SenesTech's Brandy Pyzyna to Present Fertility Control Webinar on Wednesday March 27, 2019 at 2:00pm ET (11:00am PT)

    FLAGSTAFF, Ariz., March 26, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will be presenting at a webinar on the topic of Fertility Control in Rats.  Brandy Pyzyna, Vice President of Scientific Operations and Technical Services, has authored and co-authored numerous papers and articles in the areas of fertility control and field research.  She currently leads a highly skilled team to educate customers and deploy ContraPest® in some of the most difficult environments. "The use of fertility control to manage overabundant species is not new, but it is not a widely considered tool for most rodent control programs," stated Brandy Pyzyna.  The presentation is aimed at discussing the history of fertility control in wildlife management and how fertility control can enhance integrated rodent management programs.

  • PR Newswire4 months ago

    ContraPest® Under the St. Louis Arch, Gateway to the West!

    FLAGSTAFF, Ariz., March 18, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, confirmed news reports that the City's Gateway Arch Park Foundation will continue and expand their use of ContraPest as the City of St. Louis embraces the role fertility control plays in integrated pest management.